Search results
Study explores potential target to treat liver disease
Medical Xpress· 6 days agoThe findings, published in Hepatology Communications, highlight how the therapeutic agent timolumab was able to safely block the molecule of interest, a vascular adhesion protein called VAP-1, without causing significant adverse effects.
Alcohol use disorder can be treated with an array of medications – but few people have heard of them
The Conversation via Yahoo News· 13 hours agoAlcohol is responsible for more deaths than overdoses from opioids and all other substances...
DDW 2024: Cedars-Sinai Experts Share Latest Resear | Newswise
Newswise· 5 days agoCedars-Sinai digestive and liver diseases physicians and scientists will share their latest research at the annual Digestive Disease Week meeting, that tak
Anti-inflammatory diet guide: Foods, benefits and meal plan
Daily Telegraph· 16 hours agoIgnore chronic inflammation at your peril. Recognised as a contributor to many deaths globally, half...
Celiac Disease and Fatty Liver: What’s the Connection?
Healthline· 6 days agoPeople with celiac disease seem to develop one type of fatty liver disease at higher rates. The...
Ozempic manufacturer Novo Nordisk launches study to find drug’s impact on reduced alcohol cravings
TheGrio via Yahoo News· 12 hours agoPhoto: AdobeStock The new trial will determine whether the drug, which is approved to treat type 2...
Positive trial outcomes lead BMO to maintain outperform rating on Gilead stock By Investing.com
Investing.com· 14 hours agoOn Monday, BMO (TSX:BMO) Capital maintained its Outperform rating on Gilead Sciences (NASDAQ:GILD)...
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks· 20 hours agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in liver disease progression and reduced itching in primary biliary cholangitis study.
All About Ozempic and the Next Generation of Obesity Drugs
New York Times· 16 hours agoHere’s a primer on Ozempic and other popular drugs being widely used for diabetes and weight loss....
Ozempic manufacturer Novo Nordisk launches study to find drug’s impact on reduced alcohol cravings
theGrio via AOL· 8 hours agoThe new trial will determine whether the drug, which is approved to treat type 2 diabetes, can enhance liver health by reducing liver fibrosis or scarring rather than explicitly targeting alcohol ...
